• ARK Invest in connection with the acquisition of Rize ETF Limited.
    • Chiesi Farmaceutici in connection with its proposed US$1.48 billion acquisition of Amryt Pharma PLC by way of Scheme of Arrangement.
    • One of the world's largest asset managers in connection with its Series E investment in one of Europe's leading mobility platforms.
    • Nordic Capital on the purchase of a majority shareholding in Duco Technology Limited, a leading Software as a Service (SaaS) provider to financial institutions, insurers and FinTech companies worldwide.
    • ICTS International N.V. on a secondary sale of preferred equity of Au10tix Technologies by TPG to GF GW LLC and Oak and all related shareholder arrangements.
    • Nordic Capital on the EUR 2.143 billion sale of Itiviti, a leading provider of trading technology and services to financial institutions worldwide, to NYSE listed Broadridge Financial Solutions, Inc.
    • Blackstone Credit (formerly GSO Capital Partners) on the acquisition of Co-operative Group’s general insurance business by GSO, TwinFocus and Markerstudy Group.
    • Bentley Systems in connection with the acquisition of SRO Solutions Holdings Limited and the assets of DXSTRO Software LLP.
    • Corimar Asset Management Fund LP on the sale of certain business assets of Frobisher Capital Limited to Wren Sterling.
    • Canaccord Genuity Limited in connection with an equity fundraising by Mirriad Advertising plc.
    • Bentley Systems in connection with the acquisition of Professional Construction Strategies Group Ltd, a UK-based digital built-environment consultancy.
    • Investec Bank plc in connection with a £172 million equity fundraising by ITM Power plc.
    • Seamus Lynch on its sale of a majority stake in Chill Insurance Group to Livingbridge.
    • Investcorp, a leading global manager of alternative investments, and Tages, a leading European alternative asset management firm, in connection with a 50/50 joint venture and contribution of their subsequent merger of the Absolute Return businesses to create Investcorp-Tages Limited.
    • Bentley Systems, a leading global provider of software services in connection with the acquisition of GroupBC, a UK-based SaaS software and cloud services business.
    • Share plc, the LSE listed holding company for The Share Centre, one of the UK's leading independent retail stockbrokers, on its £62 million takeover by Interactive Investor, the UK's second largest direct to consumer investment platform, which is majority owned by J.C. Flowers IV, L.P., a fund advised by J.C. Flowers & Co, LLC, a leading private investment firm.
    • Cerberus Capital Management on the sale of Covis Pharma to Apollo Global Management.
    • Judges Scientific plc on the acquisition of Moorfield Nanotechnology Limited, a manufacturer of scientific instruments.
    • ArchiMed on the acquisition of Direct Healthcare Group from NorthEdge Capital.
    • TRS Group (UK) Limited, a family owned food business, on the sale of (i) TRS Wholesale Co. Limited (ii) TRS Cash & Carry Limited and (iii) TRS International Foods Limited to Cricket Bidco Limited, a subsidiary of a fund managed by Exponent Private Equity LLP.
    • Investec Bank plc in connection with a £58.5 million equity fundraising by ITM Power plc and joint venture with Linde AG. 
    • A substantial family office as investor in a substantive venture investment in a UK ticketing and events hosting company.
    • Merck KGaA, as deal counsel on the restructure of its ongoing collaboration and acquisition option arrangements with F-Star.
    • Stripes Group on the sale of its portfolio company Audio Network Limited to Entertainment One Limited.
    • One Equity Partners on the acquisition of the MERA group, a custom software developments services provider.
    • Quilvest Private Equity on the acquisition of global specialist recruitment firm Phaidon International.
    • Prexton Therapeutics B.V. and its selling shareholders, including M Ventures, in its sale to global pharmaceutical company H. Lundbeck A/S for up to €905 million.
    • The shareholders on the sale of Stat-Dx, a privately owned Spanish diagnostics company, to QIAGEN N.V., for US$191 million (including milestones).